United Kingdom (UK) Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026

October 2022 | 47 pages | ID: U91331875553EN
MarketLine

Abstracts

United Kingdom (UK) Biotechnology Market @Summary, Competitive Analysis and Forecast, 2017-2026

SUMMARY

Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
• The UK biotechnology market had total revenues of $20.5 billion in 2021, representing a compound annual growth rate (CAGR) of 16.9% between 2016 and 2021.
• The medical/healthcare segment generated the most revenue in 2021, with total revenues of $13.5 billion, equivalent to 66% of the market's overall value.
• As in many other developed countries, the UK’s aging population is driving demand in the medical/healthcare segment as more people suffer from long-term chronic diseases. Biotech plays an important role here.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United Kingdom
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts by both value and volume

REASONS TO BUY

• What was the size of the United Kingdom biotechnology market by value in 2021?
• What will be the size of the United Kingdom biotechnology market in 2026?
• What factors are affecting the strength of competition in the United Kingdom biotechnology market?
• How has the market performed over the last five years?
• Who are the top competitors in the United Kingdom's biotechnology market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?

8 COMPANY PROFILES

8.1. AstraZeneca PLC
8.2. Novartis AG
8.3. GE Healthcare
8.4. GSK plc.

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: United Kingdom biotechnology industry value: $ billion, 2016–21
Table 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: United Kingdom biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: United Kingdom biotechnology industry geography segmentation: $ billion, 2021
Table 5: United Kingdom biotechnology industry value forecast: $ billion, 2021–26
Table 6: AstraZeneca PLC: key facts
Table 7: AstraZeneca PLC: Annual Financial Ratios
Table 8: AstraZeneca PLC: Key Employees
Table 9: Novartis AG: key facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Novartis AG: Key Employees Continued
Table 13: GE Healthcare: key facts
Table 14: GE Healthcare: Key Employees
Table 15: GE Healthcare: Key Employees Continued
Table 16: GSK plc.: key facts
Table 17: GSK plc.: Annual Financial Ratios
Table 18: GSK plc.: Key Employees
Table 19: GSK plc.: Key Employees Continued
Table 20: United Kingdom size of population (million), 2017–21
Table 21: United Kingdom gdp (constant 2005 prices, $ billion), 2017–21
Table 22: United Kingdom gdp (current prices, $ billion), 2017–21
Table 23: United Kingdom inflation, 2017–21
Table 24: United Kingdom consumer price index (absolute), 2017–21
Table 25: United Kingdom exchange rate, 2017–21

List Of Figures

LIST OF FIGURES

Figure 1: United Kingdom biotechnology industry value: $ billion, 2016–21
Figure 2: United Kingdom biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: United Kingdom biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2021